CT-FFR analysis shows patient’s level of cardiac obstruction and location, guiding treatment
The patient In July 2022, a 45-year-old male with a six-year history of chest pain went to the emergency room complaining of chest discomfort and shortness of breath over the previous two weeks. He was [...]
View more
Advances in hyperlipidemia medications put cholesterol goals in reach for more patients
Diet and exercise many times are not enough to lower the risk of hyperlipidemia (HLD). As we’ve learned over the years, genetics can play the biggest role. Fortunately, we now have treatments we didn’t have […]
View more
Advanced Heart Failure Referral Guidelines
When symptoms of heart failure begin progressing or patients start decompensating, there is a brief opportunity for referral to an advanced heart failure center. The American Heart Association calls this the “golden window.” Providers should […]
View more
Mavacamten, a new treatment for hypertrophic cardiomyopathy is changing lives
A new, first-in-its-class treatment for hypertrophic cardiomyopathy, mavacamten, has been a game-changer for my patients with obstruction. In April, the Food and Drug Administration (FDA) gave breakthrough therapy designation and orphan drug designation for the […]
View more
Neurohormonal blockade in heart failure
Newly diagnosed heart failure patients have a three-month window of care crucial to their likelihood of recovery. The difference can be returning to a normal life versus awaiting a heart transplant or mechanical circulatory support […]
View more
Lauren R. Albers, M.D., joins Norton Heart & Vascular Institute to focus on women’s cardiology
Lauren R. Albers, M.D., has joined Norton Heart & Vascular Institute to focus on women’s cardiology. Dr. Albers, who completed her fellowship in cardiovascular medicine at the UofL School of Medicine, joins the Norton Heart […]
View more
Structural Heart Program offers multidisciplinary care
A new Structural Heart Program offers our patients a truly comprehensive approach, reducing the number of clinic visits and shortening the time from diagnosis to treatment. The Structural Heart Program is a combination of expertise […]
View more
Evidence growing in favor of ablation for atrial fibrillation
Ablation for paroxysmal atrial fibrillation (A-fib) has been shown to be superior to medical management for the maintenance of sinus rhythm. Now, newer ablation techniques are making the procedure safer, more efficient and effective. The [...]
View more
Treating amyloid cardiomyopathy (ATTR-CM) with tafamidis
New treatments are available for patients with transthyretin amyloid cardiomyopathy (ATTR-CM), a rare, underdiagnosed condition that causes faulty proteins to build up in the heart. Untreated, the condition leads to heart failure and death. An […]
View more
Health disparities in cardiology
In a recent continuing medical education presentation, Kelly C. McCants, M.D., executive medical director, Norton Heart & Vascular Institute Advanced Heart Failure & Recovery Program, and executive director, Institute for Health Equity, a Part of […]
View more
Features of systolic murmur
A heart murmur is a sound that can be heard via stethoscope. These whooshing or swishing sounds are caused when blood flow is turbulent as it moves through the heart. A normal heartbeat makes a […]
View more
Hybrid ablation for persistent atrial fibrillation
Hybrid ablation is used as treatment for long-standing persistent atrial fibrillation (A-fib), the most severe form of the condition affecting about 45% of A-fib patients. Steven M. Peterson, M.D., cardiothoracic surgeon with Norton Heart & […]
View more